Paper36976157
Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis.
Wilson L and 4 others. Transl Vis Sci Technol, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis. Papers, record 36976157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36976157
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Uveitis | Major topic |
| Rats | |
| Humans | |
| Animals | |
| CD28 Antigens | |
| Rats, Inbred Lew | |
| T-Lymphocytes | |
| Recombinant Fusion Proteins |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 DK017047 | NIDDK NIH HHS | United States | P30DK017047 | PubMed and NIH | NIH RePORTER |
| P30 EY001730 | NEI NIH HHS | United States | P30EY001730 | PubMed and NIH | NIH RePORTER |
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33823429 | A review on applications of abatacept in systemic rheumatic diseases. | Int Immunopharmacol | 2021 | https://conductscience.org/library/papers/33823429 | PubMed |
| 2 | 35498797 | Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience. | Front Pediatr | 2022 | https://conductscience.org/library/papers/35498797 | PubMed |
| 3 | 27633826 | Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis. | J Rheumatol | 2016 | https://conductscience.org/library/papers/27633826 | PubMed |
| 4 | 19748676 | Methotrexate for ocular inflammatory diseases. | Ophthalmology | 2009 | https://conductscience.org/library/papers/19748676 | PubMed |
| 5 | 32459545 | Effect of In Vivo Expansion of Regulatory T Cells with IL-2/anti-IL-2 Antibody Complex Plus Rapamycin on Experimental Autoimmune Uveoretinitis. | Ocul Immunol Inflamm | 2021 | https://conductscience.org/library/papers/32459545 | PubMed |
| 6 | 11046032 | Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. | J Immunol | 2000 | https://conductscience.org/library/papers/11046032 | PubMed |
| 7 | 25178807 | Long-term clinical outcome and causes of vision loss in patients with uveitis. | Ophthalmology | 2014 | https://conductscience.org/library/papers/25178807 | PubMed |
| 8 | 25774330 | One-Year Outcomes of the SAVE Study: Sirolimus as a Therapeutic Approach for UVEitis. | Transl Vis Sci Technol | 2015 | https://conductscience.org/library/papers/25774330 | PubMed |
| 9 | 28248972 | Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production. | PLoS One | 2017 | https://conductscience.org/library/papers/28248972 | PubMed |
| 10 | 20042178 | Mycophenolate mofetil for ocular inflammation. | Am J Ophthalmol | 2010 | https://conductscience.org/library/papers/20042178 | PubMed |
| 11 | 24917273 | A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. | Ophthalmology | 2014 | https://conductscience.org/library/papers/24917273 | PubMed |
| 12 | 34632541 | Intraocular therapy in noninfectious uveitis. | J Ophthalmic Inflamm Infect | 2021 | https://conductscience.org/library/papers/34632541 | PubMed |
| 13 | 26971048 | Topical ocular dexamethasone decreases intraocular pressure and body weight in rats. | J Negat Results Biomed | 2016 | https://conductscience.org/library/papers/26971048 | PubMed |
| 14 | 11581203 | Relationship between aqueous humor protein level and outflow facility in patients with uveitis. | Invest Ophthalmol Vis Sci | 2001 | https://conductscience.org/library/papers/11581203 | PubMed |
| 15 | 6971281 | Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution. | Invest Ophthalmol Vis Sci | 1981 | https://conductscience.org/library/papers/6971281 | PubMed |
| 16 | 32564920 | Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program. | Ophthalmology | 2020 | https://conductscience.org/library/papers/32564920 | PubMed |
| 17 | 12084735 | Visual impairment and blindness in Europe and their prevention. | Br J Ophthalmol | 2002 | https://conductscience.org/library/papers/12084735 | PubMed |
| 18 | 32886537 | Definition of Uveitis Refractory to Treatment: A Systematic Review in the Absence of a Consensus. | Ocul Immunol Inflamm | 2022 | https://conductscience.org/library/papers/32886537 | PubMed |
| 19 | 12876557 | Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. | Nat Rev Immunol | 2003 | https://conductscience.org/library/papers/12876557 | PubMed |
| 20 | 3106257 | Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. | Invest Ophthalmol Vis Sci | 1987 | https://conductscience.org/library/papers/3106257 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD80 | 941 | PubTator's text mining | https://conductscience.org/library/genes/941 | NCBI Gene |
| CD86 | 942 | PubTator's text mining | https://conductscience.org/library/genes/942 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| ICOS | 29851 | PubTator's text mining | https://conductscience.org/library/genes/29851 | NCBI Gene |
| IL17A | 3605 | PubTator's text mining | https://conductscience.org/library/genes/3605 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| LOC102723996 | 102723996 | PubTator's text mining | https://conductscience.org/library/genes/102723996 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36976157
GET https://conductscience.org/api/papers/v1/36976157/references?page=2